1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Pharmacovigilance Market
4. France Pharmacovigilance Market by
Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. France Pharmacovigilance Market by
Service Provider
5.1. In House
5.2. Contract Outsourcing
6. France Pharmacovigilance Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. France Pharmacovigilance Market by
End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Pharmacovigilance Market
4. France Pharmacovigilance Market by
Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. France Pharmacovigilance Market by
Service Provider
5.1. In House
5.2. Contract Outsourcing
6. France Pharmacovigilance Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. France Pharmacovigilance Market by
End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5